Report of the 3rd and 4th Mystery of Reactive Oxygen Species Conference
Article Sidebar
Main Article Content
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles are distributed under the terms of the Creative Commons Attribution 4.0 International license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is appropriately cited (CC-BY). Copyright on any article in ALTEX is retained by the author(s).
Carusi, A., Filipovska, J., Wittwehr, C. et al. (2023). CIAO: aA living experiment in interdisciplinary large-scale collaboration facilitated by the adverse outcome pathway framework. Front Public Health 11, 1212544. doi:10.3389/fpubh.2023.1212544
Clerbaux, L.-A., Albertini, M. C., Amigó, N. et al. (2022a). Factors modulating COVID-19: A mechanistic understanding based on the adverse outcome pathway framework. J Clin Med 11, 4464. doi:10.3390/jcm11154464
Clerbaux, L.-A., Fillipovska, J., Muñoz, A. et al. (2022b). Mechanisms leading to gut dysbiosis in COVID-19: Current evidence and uncertainties based on adverse outcome pathways. J Clin Med 11, 5400. doi:10.3390/jcm11185400
Clerbaux, L.-A., Mayasich, S. A., Muñoz, A. et al. (2022c). Gut as an alternative entry route for SARS-CoV-2: Current evidence and uncertainties of productive enteric infection in COVID-19. J Clin Med 11, 5691. doi:10.3390/jcm11195691
Clerbaux, L. A., Amigó, N., Amorim, M. J. et al. (2022d). COVID-19 through adverse outcome pathways: Building networks to better understand the disease – 3rd CIAO AOP design workshop. ALTEX 39, 322-335. doi:10.14573/altex.2112161
Hogberg, H. T., Lam, A., Ohayon, E. et al. (2022). The adverse outcome pathway framework applied to neurological symptoms of COVID-19. Cells 11, 3411. doi:10.3390/cells11213411
Ives, C., Campia, I., Wang, R. L. et al. (2017). Creating a structured AOP knowledgebase via ontology-based annotations. Appl In Vitro Toxicol 3, 298-311. doi:10.1089/aivt.2017.0017
Nymark, P., Sachana, M., Leite, S. B. et al. (2021). Systematic organization of COVID-19 data supported by the adverse outcome pathway framework. Front Public Health 9, 638605. doi:10.3389/fpubh.2021.638605
Shahbaz, M. A., De Bernardi, F., Alatalo, A. et al. (2022). Mechanistic understanding of the olfactory neuroepithelium involvement leading to short-term anosmia in COVID-19 using the adverse outcome pathway framework. Cells 11, 3027. doi:10.3390/cells11193027
Tanabe, S., Beaton, D., Chauhan, V. et al. (2022a). Report of the 1st and 2nd mystery of reactive oxygen species conferences. ALTEX 39, 336-338. doi:10.14573/altex.2203011
Tanabe, S., O’Brien, J., Tollefsen, K. E. et al., (2022b). Reactive oxygen species in the adverse outcome pathway framework: Toward creation of harmonized consensus key events. Front Toxicol 4, 887135. doi:10.3389/ftox.2022.887135
Vinken, M. (2021). Covid-19 and the liver: An adverse outcome pathway perspective. Toxicology 455, 152765. doi:10.1016/j.tox.2021.152765
Wittwehr, C., Amorim, M. J., Clerbaux, L. A. et al. (2021). Understanding covid-19 through adverse outcome pathways – 2nd CIAO AOP design workshop. ALTEX 38, 351-357. doi:10.14573/altex.2102221
Wittwehr, C., Chang, X., Bisson, W. et al., (2023). Methods2AOP: An International Collaboration to Integrate Assay Annotations into the AOP Key Event Descriptions. https://ntp.niehs.nih.gov/sites/default/files/iccvam/meetings/sot23/sot2023-wittwehr-poster.pdf